The Net Margin of WuXi Biologics (Cayman) Inc (2269.HK) is 17.97%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 17.97% |
| 2023-12-31 | 19.96% |
| 2022-12-31 | 28.95% |
| 2021-12-31 | 32.93% |
| 2020-12-31 | 30.09% |
| 2019-12-31 | 25.45% |
| 2018-12-31 | 24.88% |
| 2017-12-31 | 15.61% |
| 2016-12-31 | 14.27% |
| 2015-12-31 | 7.99% |